Vanguard Portfolio Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Vanguard Portfolio Management's CDNA Position: Q2 2026 in Review
Vanguard Portfolio Management increased its CareDx (CDNA) stake by 16% in Q2 2026, buying an estimated $3.01M and bringing the position to 989,529 shares worth $28.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1873.
Vanguard Portfolio Management first reported a position in CDNA in Q1 2026 and has held it in 2 quarters since. 225 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Vanguard Portfolio Management held 989,529 shares of CareDx worth $28.2M as of Q2 2026.
- Vanguard Portfolio Management bought 138,096 CareDx shares in Q2 2026, an estimated $3.01M.
- CareDx made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1873 holding.
- Vanguard Portfolio Management first reported a position in CareDx in Q1 2026 and has held it in 2 quarters since.
- 225 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.